Skip to main content

Table 1 Baseline characteristics of the study population

From: Coagulation abnormalities in childhood acute lymphoblastic leukemia: assessing the impact of L-asparaginase therapy in Ghana

Variables

Control (n = 78)

Case (n = 26)

p-value

Age (yrs)/mean ± SD

8.62 ± 3.61

9.88 ± 2.86

0.107

Sex

  

1.000*

 Females/n (%)

38 (48.7)

12 (46.2)

 

 Males/n (%)

40 (51.3)

14 (53.8)

 

Weight (Kg) /mean ± SD

29.28 ± 11.21

30.19 ± 8.75

0.671

Height (m) /mean ± SD

1.27 ± 0.22

1.35 ± 0.15

0.025

BMI(Kg/m2) /mean ± SD

17.52 ± 1.84

16.16 ± 2.15

0.002

Lymphadenopathy

0 (0.0)

6 (23.1)

< 0.0001*

Hepatomegaly

0 (0.0)

7 (26.9)

< 0.0001*

Treatment

  

NA

 Newly diagnosed

4 (15.4)

 

 On treatment

22 (84.6)

 

Induction

7 (26.9)

NA

Consolidation

4 (15.4)

NA

Maintenance

11 (42.3)

NA

  1. Unless otherwise indicated, statistical analyses were performed using independent t-tests. *: statistical analysis was done using Chi-squared/Fisher’s exact test. NA Non-applicable